Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 11 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
LABORATOIRES OXYFORM from Mouscron, company number BE0763626758, closed financial year 2025 with a result of € -163,279 after tax. For that financial year LABORATOIRES OXYFORM recorded a gross margin of € -48,346 and equity of € -2.7 million. Compared with financial year 2024, the result moved from € -164,772 to € -163,279. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ -2.7 million
▼ € 163,279 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -163,279
▲ 1 % less loss than in 2024
Profit after tax over the fiscal year.
€ 21,937
▼ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.7 million.
People and assets in 2025
€ 75,993
▼ 57% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,105
▼ 62% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 66,599
▲ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,765
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -916,192 | € -7,874 | € 67,895 | € -48,346 | ▼ € 116,242 |
| Profit after taxes | € -1,344,044 | € -252,581 | € -164,772 | € -163,279 | ▲ € 1,492 |
| Equity | € -2,117,019 | € -2,369,601 | € -2,534,372 | € -2,697,651 | ▼ € 163,279 |
| Total debts | € 2,323,036 | € 2,623,356 | € 2,857,767 | € 2,900,619 | ▲ 1% |
| Cash | € 5,775 | € 7,157 | € 27,499 | € 21,937 | ▼ 20% |
| Retained profit | € -2,127,019 | € -2,379,601 | € -2,544,372 | € -2,707,651 | ▼ € 163,279 |
| Balance sheet total | € 206,017 | € 253,755 | € 323,395 | € 202,968 | ▼ 37% |
Key figures of LABORATOIRES OXYFORM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LABORATOIRES OXYFORM?
What happened at LABORATOIRES OXYFORM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 163,279. filed late Source: NBB ↗
- New establishment in Mouscron. KBO
- Start of the company according to the CBE. KBO
- PY-ONE ENT E became a director. NBB
- JOMELINE STRATEGIE ENT E became a director. NBB
In short
From € 1.3 million loss in 2022 to € 163,279 loss in 2025.
Paid € 13,667 in corporate taxes since 2022.
A new publication or filing at LABORATOIRES OXYFORM? We notify you, reason included.
Follow LABORATOIRES OXYFORMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind LABORATOIRES OXYFORM are PY-ONE ENT E and JOMELINE STRATEGIE ENT E.
Directors
According to the 2025 annual accounts
Administrator-manager · represented by PAUL Yves
since 2021
Director · represented by EUVRARD Pascal
since 2021
Establishments
Establishment units
Physical locations of this company
Schermutselingstraat 1
7700 Mouscron
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Biral Lubricants
€ 67,105 gross margin · 2025
BUREAU CNOCKAERT
€ 465,862 gross margin · 2025
PLANNING
€ 100,975 gross margin · 2024
Chauffage Damien Corne
€ 71,636 gross margin · 2025
SODIFIL
€ 843,075 revenue · 2023
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0763.626.758
- VAT number
- BE 0763.626.758
- Registered office
- Schermutselingstraat 1, 7700 Mouscron
- Names & denominations
- LABORATOIRES OXYFORM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 February 2021
- Peppol
- Active · Active since 11 Oct 2024
- Activities · NACE
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.